APS vs. RVX, ATE, AEZS, MBX, BCT, HBP, and TH
Should you be buying Aptose Biosciences stock or one of its competitors? The main competitors of Aptose Biosciences include Resverlogix (RVX), Antibe Therapeutics (ATE), Aeterna Zentaris (AEZS), Microbix Biosystems (MBX), BriaCell Therapeutics (BCT), Helix BioPharma (HBP), and Theratechnologies (TH). These companies are all part of the "biotechnology" industry.
Resverlogix (TSE:RVX) and Aptose Biosciences (TSE:APS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, community ranking, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.
9.8% of Aptose Biosciences shares are owned by institutional investors. 43.2% of Resverlogix shares are owned by company insiders. Comparatively, 20.2% of Aptose Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Resverlogix received 98 more outperform votes than Aptose Biosciences when rated by MarketBeat users. Likewise, 84.01% of users gave Resverlogix an outperform vote while only 72.11% of users gave Aptose Biosciences an outperform vote.
Resverlogix is trading at a lower price-to-earnings ratio than Aptose Biosciences, indicating that it is currently the more affordable of the two stocks.
Resverlogix has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, Aptose Biosciences has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500.
Aptose Biosciences' return on equity of 0.00% beat Resverlogix's return on equity.
In the previous week, Aptose Biosciences' average media sentiment score of 0.00 equaled Resverlogix'saverage media sentiment score.
Summary
Resverlogix beats Aptose Biosciences on 7 of the 10 factors compared between the two stocks.
Get Aptose Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding APS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aptose Biosciences Competitors List
Related Companies and Tools
